Table 2.
Selected disease and function enrichment.
| Diseases or functions |
No. of miRNAs |
P-value | miRNAs |
|---|---|---|---|
| Digestive system cancer | 22 | 4.58E-02 | let-7f-5p, miR-10a-5p, miR-128-3p, miR-139-5p, miR-148a-3p, miR-151-3p, miR-16-5p, miR-17-5p, miR-183-5p, miR-200b-3p, miR-203a-3p, miR-214-3p, miR-324-5p, miR-329-3p, miR-34c-5p, miR-361-3p, miR-421-3p, miR-423-5p, miR-671-3p, miR-874-3p, miR-92a-3p, miR-122-5p |
| Gastrointestinal tract cancer | 20 | 4.81E-04 | let-7f-5p, miR-10a-5p, miR-128-3p, miR-139-5p, miR-148a-3p, miR-151-3p, miR-16-5p, miR-17-5p, miR-183-5p, miR-200b-3p, miR-203a-3p, miR-214-3p, miR-324-5p, miR-329-3p, miR-34c-5p, miR-361-3p, miR-421-3p, miR-423-5p, miR-874-3p, miR-92a-3p |
| Liver cancer | 13 | 9.26E-02 | let-7f-5p, miR-10a-5p, miR-148a-3p, miR-151-3p, miR-16-5p, miR-17-5p, miR-183-5p, miR-200b-3p, miR-203a-3p, miR-34c-5p, miR-671-3p, miR-92a-3p, miR-122-5p |
| Hepatocellular carcinoma | 8 | 4.12E-06 | let-7f-5p, miR-148a-3p, miR-16-5p, , miR-122-5p, miR-17-5p, miR-183-5p, miR-34c-5p, miR-92a-3p |
| Hematologic cancer | 10 | 2.09E-03 | let-7f-5p, miR-101-3p, miR-10a-5p, miR-148a-3p, miR-16-5p, miR-17-5p, miR-342-5p, miR-34c-5p, miR-361-3p, miR-92a-3p |
| Proliferation of cells | 16 | 2.76E-03 | let-7f-5p, miR-101-3p, miR-10a-5p, miR-128-3p, miR-139-5p, miR-148a-3p, miR-16-5p, miR-17-5p, miR-182-5p, miR-183-5p, miR-185-5p, miR-200b-3p, miR-203a-3p, miR-34c-5p, miR-92a-3p, miR-122-5p |
| Cell apoptosis | 10 | 3.08E-02 | let-7f-5p,miR-122-5p,miR-16-5p,miR-17-5p,miR-183-5p,miR-185-5p,miR-200b-3p,miR-203a-3p,miR-214-3p,miR-34c-5p |
| Inflammation of organ | 10 | 4.03E-05 | let-7f-5p, miR-16-5p, miR-17-5p, miR-185-5p, miR-200b-3p, miR-203a-3p, miR-324-5p, miR-423-3p, miR-423-5p, miR-92a-3p |